BCRP has been reported to induce drug resistant phenotype of NRF2 dependance by increasing the efflux of 5-FU in breast cancer cells[33] and Irinotecan, Topotecan and Mitoxantrone in colorectal cancer cells[32,34]. This evidence concerns the gene NFE2L2 and breast carcinoma.